A randomized safety and feasibility crossover trial of two Mediterranean-ketogenic interventions in individuals with Parkinson's disease. - Tosefsky K; Lam JS; Wang YN; Keymanesh S; Kuan AJ; Metcalfe-Roach A; Cirstea MS; Sacheli MA; Brett Finlay B; Cohen TR; Appel-Cresswell S (Journal of Parkinson's disease, 2026)